BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8512635)

  • 21. Temporal relationship between depressive symptoms and cognitive impairment: the Italian Longitudinal Study on Aging.
    Panza F; D'Introno A; Colacicco AM; Capurso C; Del Parigi A; Caselli RJ; Frisardi V; Scapicchio P; Chiloiro R; Scafato E; Gandin C; Vendemiale G; Capurso A; Solfrizzi V
    J Alzheimers Dis; 2009; 17(4):899-911. PubMed ID: 19542612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The episodic buffer and learning in early Alzheimer's disease.
    Germano C; Kinsella GJ; Storey E; Ong B; Ames D
    J Clin Exp Neuropsychol; 2008 Aug; 30(6):627-38. PubMed ID: 18612873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The outcome of elderly patients with cognitive complaints but normal neuropsychological tests.
    Nunes T; Fragata I; Ribeiro F; Palma T; Maroco J; Cannas J; Secca M; Menezes C; Carmo I; Cunha G; Castelo Branco M; Guerreiro M; de Mendonça A
    J Alzheimers Dis; 2010; 19(1):137-45. PubMed ID: 20061633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attentional processes discriminate between patients with mild Alzheimer's disease and cognitively healthy elderly.
    Gorus E; De Raedt R; Lambert M; Lemper JC; Mets T
    Int Psychogeriatr; 2006 Sep; 18(3):539-49. PubMed ID: 16472408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-sectional neurocognitive data do not support a transition from fibrofog to Alzheimer disease in fibromyalgia patients.
    Leavitt F; Katz RS
    J Clin Rheumatol; 2015 Mar; 21(2):81-5. PubMed ID: 25710859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal cognitive decline in patients with Alzheimer's disease.
    Rebok G; Brandt J; Folstein M
    J Geriatr Psychiatry Neurol; 1990; 3(2):91-7. PubMed ID: 2206264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive estimation impairment in Alzheimer disease and mild cognitive impairment.
    Levinoff EJ; Phillips NA; Verret L; Babins L; Kelner N; Akerib V; Chertkow H
    Neuropsychology; 2006 Jan; 20(1):123-32. PubMed ID: 16460228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting disease progression in Alzheimer's disease: the role of neuropsychiatric syndromes on functional and cognitive decline.
    Palmer K; Lupo F; Perri R; Salamone G; Fadda L; Caltagirone C; Musicco M; Cravello L
    J Alzheimers Dis; 2011; 24(1):35-45. PubMed ID: 21157019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a neuropsychological battery for the Leukoaraiosis and Disability in the Elderly Study (LADIS): experience and baseline data.
    Madureira S; Verdelho A; Ferro J; Basile AM; Chabriat H; Erkinjuntti T; Fazekas F; Hennerici M; O'brien J; Pantoni L; Salvadori E; Scheltens P; Visser MC; Wahlund LO; Waldemar G; Wallin A; Inzitari D;
    Neuroepidemiology; 2006; 27(2):101-16. PubMed ID: 16943684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
    Amieva H; Le Goff M; Millet X; Orgogozo JM; Pérès K; Barberger-Gateau P; Jacqmin-Gadda H; Dartigues JF
    Ann Neurol; 2008 Nov; 64(5):492-8. PubMed ID: 19067364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.
    Gomar JJ; Bobes-Bascaran MT; Conejero-Goldberg C; Davies P; Goldberg TE;
    Arch Gen Psychiatry; 2011 Sep; 68(9):961-9. PubMed ID: 21893661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease.
    Egerházi A; Berecz R; Bartók E; Degrell I
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):746-51. PubMed ID: 17289240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A delayed recall battery as a sensitive screening for mild cognitive impairment: follow-up study of memory clinic patients after 10 years.
    Takayama Y
    J Med Dent Sci; 2010 Jun; 57(2):177-84. PubMed ID: 21073136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The neuropsychological profiles of mild Alzheimer's disease and questionable dementia as compared to age-related cognitive decline.
    Vliet EC; Manly J; Tang MX; Marder K; Bell K; Stern Y
    J Int Neuropsychol Soc; 2003 Jul; 9(5):720-32. PubMed ID: 12901778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy.
    Modrego PJ; Fayed N; Pina MA
    Am J Psychiatry; 2005 Apr; 162(4):667-75. PubMed ID: 15800137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive patterns of normal elderly subjects are consistent with frontal cortico-subcortical and fronto-parietal neuropsychological models of brain aging.
    Gawron N; Łojek E; Kijanowska-Haładyna B; Nestorowicz J; Harasim A; Pluta A; Sobańska M
    Appl Neuropsychol Adult; 2014; 21(3):195-209. PubMed ID: 25084844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive decline in patients with familial Alzheimer's disease associated with E280a presenilin-1 mutation: a longitudinal study.
    Rosselli MC; Ardila AC; Moreno SC; Standish VC; Arango-Lasprilla JC; Tirado VM; Ossa JM; Goate AM; Kosik KS; Lopera F
    J Clin Exp Neuropsychol; 2000 Aug; 22(4):483-95. PubMed ID: 10923058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early detection of isolated memory deficits in the elderly: the need for more sensitive neuropsychological tests.
    de Jager CA; Milwain E; Budge M
    Psychol Med; 2002 Apr; 32(3):483-91. PubMed ID: 11989993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired visual recognition memory predicts Alzheimer's disease in amnestic mild cognitive impairment.
    Didic M; Felician O; Barbeau EJ; Mancini J; Latger-Florence C; Tramoni E; Ceccaldi M
    Dement Geriatr Cogn Disord; 2013; 35(5-6):291-9. PubMed ID: 23572062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer's disease: a cross-sectional and longitudinal study of 55 cases.
    Lambon Ralph MA; Patterson K; Graham N; Dawson K; Hodges JR
    Brain; 2003 Nov; 126(Pt 11):2350-62. PubMed ID: 12876147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.